{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:59:09Z","timestamp":1790240349855,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82102185"],"award-info":[{"award-number":["82102185"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"DOI":"10.1007\/s10571-026-01819-2","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T17:54:51Z","timestamp":1788803691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic Prioritization of Plasma Proteins Across Dementia Subtypes: A Proteome-Wide Mendelian Randomization and Bayesian Colocalization Analysis"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0919-8698","authenticated-orcid":false,"given":"Xinyang","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinning","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"1819_CR1","doi-asserted-by":"publisher","DOI":"10.64898\/2025.12.08.25341836","author":"N Amin","year":"2025","unstructured":"Amin N, Kaushik P, Belbasis L, Xiao S, Argentieri MA, Ahmad S et al (2025) Proteomic profiling of Alzheimer\u2019s disease and Vascular dementia reveals unique underlying signatures. medRxiv. https:\/\/doi.org\/10.64898\/2025.12.08.25341836","journal-title":"medRxiv"},{"issue":"4","key":"1819_CR2","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s1474-4422(19)30435-1","volume":"19","author":"SJ Andrews","year":"2020","unstructured":"Andrews SJ, Fulton-Howard B, Goate A (2020) Interpretation of risk loci from genome-wide association studies of Alzheimer\u2019s disease. Lancet Neurol 19(4):326\u2013335. https:\/\/doi.org\/10.1016\/s1474-4422(19)30435-1","journal-title":"Lancet Neurol"},{"issue":"7","key":"1819_CR3","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1093\/brain\/awaf018","volume":"148","author":"L Belbasis","year":"2025","unstructured":"Belbasis L, Morris S, van Duijn C, Bennett D, Walters R (2025) Mendelian randomization identifies proteins involved in neurodegenerative diseases. Brain 148(7):2412\u20132428. https:\/\/doi.org\/10.1093\/brain\/awaf018","journal-title":"Brain"},{"issue":"1","key":"1819_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14156-4","volume":"11","author":"S Burgess","year":"2020","unstructured":"Burgess S, Foley CN, Allara E, Staley JR, Howson JMM (2020) A robust and efficient method for Mendelian randomization with hundreds of genetic variants. Nat Commun 11(1):376. https:\/\/doi.org\/10.1038\/s41467-019-14156-4","journal-title":"Nat Commun"},{"issue":"5","key":"1819_CR5","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1177\/0962280215597579","volume":"26","author":"S Burgess","year":"2017","unstructured":"Burgess S, Small DS, Thompson SG (2017) A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res 26(5):2333\u20132355. https:\/\/doi.org\/10.1177\/0962280215597579","journal-title":"Stat Methods Med Res"},{"issue":"1","key":"1819_CR6","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1086\/381000","volume":"74","author":"CS Carlson","year":"2004","unstructured":"Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA (2004) Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 74(1):106\u2013120. https:\/\/doi.org\/10.1086\/381000","journal-title":"Am J Hum Genet"},{"issue":"3","key":"1819_CR7","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia R, Sabir MS, Bandres-Ciga S, Saez-Atienzar S, Reynolds RH, Gustavsson E et al (2021) Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat Genet 53(3):294\u2013303. https:\/\/doi.org\/10.1038\/s41588-021-00785-3","journal-title":"Nat Genet"},{"issue":"2","key":"1819_CR8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/01677063.2020.1866569","volume":"35","author":"D Curtis","year":"2021","unstructured":"Curtis D (2021) Analysis of whole genome sequenced cases and controls shows that the association of variants in TOMM40, BCAM, NECTIN2 and APOC1 with late onset Alzheimer\u2019s disease is driven by linkage disequilibrium with APOE \u03b52\/\u03b53\/\u03b54 alleles. J Neurogenet 35(2):59\u201366. https:\/\/doi.org\/10.1080\/01677063.2020.1866569","journal-title":"J Neurogenet"},{"key":"1819_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G (2018) Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ 362:k601. https:\/\/doi.org\/10.1136\/bmj.k601","journal-title":"BMJ"},{"issue":"8","key":"1819_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrneurol.2017.96","volume":"13","author":"FM Elahi","year":"2017","unstructured":"Elahi FM, Miller BL (2017) A clinicopathological approach to the diagnosis of dementia. Nat Rev Neurol 13(8):457\u2013476. https:\/\/doi.org\/10.1038\/nrneurol.2017.96","journal-title":"Nat Rev Neurol"},{"key":"1819_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J et al (2017) The druggable genome and support for target identification and validation in drug development. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aag1166","journal-title":"Sci Transl Med"},{"issue":"D1","key":"1819_CR12","doi-asserted-by":"publisher","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","volume":"49","author":"SL Freshour","year":"2021","unstructured":"Freshour SL, Kiwala S, Cotto KC, Coffman AC, McMichael JF, Song JJ et al (2021) Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts. Nucleic Acids Res 49(D1):D1144\u2013d1151. https:\/\/doi.org\/10.1093\/nar\/gkaa1084","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1819_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C et al (2014) Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet 10(5):e1004383. https:\/\/doi.org\/10.1371\/journal.pgen.1004383","journal-title":"PLoS Genet"},{"key":"1819_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2025.157072","volume":"197","author":"X Guo","year":"2026","unstructured":"Guo X, Tang P, He J, Li R (2026) Dissecting the effect of blood colony-stimulating factors and receptors on Alzheimer\u2019s disease: the role of myeloid traits and inflammation. Cytokine 197:157072. https:\/\/doi.org\/10.1016\/j.cyto.2025.157072","journal-title":"Cytokine"},{"issue":"2","key":"1819_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s43587-023-00565-0","volume":"4","author":"Y Guo","year":"2024","unstructured":"Guo Y, You J, Zhang Y, Liu WS, Huang YY, Zhang YR et al (2024) Plasma proteomic profiles predict future dementia in healthy adults. Nat Aging 4(2):247\u2013260. https:\/\/doi.org\/10.1038\/s43587-023-00565-0","journal-title":"Nat Aging"},{"issue":"1","key":"1819_CR16","doi-asserted-by":"publisher","first-page":"e12280","DOI":"10.1002\/dad2.12280","volume":"14","author":"RF Hillary","year":"2022","unstructured":"Hillary RF, Gadd DA, McCartney DL, Shi L, Campbell A, Walker RM et al (2022) Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer\u2019s disease implicate TBCA and TREM2 in disease risk. Alzheimers Dement (Amst) 14(1):e12280. https:\/\/doi.org\/10.1002\/dad2.12280","journal-title":"Alzheimers Dement (Amst)"},{"issue":"3","key":"1819_CR17","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S et al (2019) Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet 51(3):404\u2013413. https:\/\/doi.org\/10.1038\/s41588-018-0311-9","journal-title":"Nat Genet"},{"issue":"7944","key":"1819_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508\u2013518. https:\/\/doi.org\/10.1038\/s41586-022-05473-8","journal-title":"Nature"},{"issue":"2","key":"1819_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1177\/13872877251345151","volume":"106","author":"Y Li","year":"2025","unstructured":"Li Y, Yao YL, Wu Y (2025) Causal relationships between plasma proteins and Alzheimer\u2019s disease using bidirectional Mendelian randomization. J Alzheimers Dis 106(2):765\u2013773. https:\/\/doi.org\/10.1177\/13872877251345151","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"1819_CR20","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/joim.12959","volume":"286","author":"R Loera-Valencia","year":"2019","unstructured":"Loera-Valencia R, Cedazo-Minguez A, Kenigsberg PA, Page G, Duarte AI, Giusti P et al (2019) Current and emerging avenues for Alzheimer\u2019s disease drug targets. J Intern Med 286(4):398\u2013437. https:\/\/doi.org\/10.1111\/joim.12959","journal-title":"J Intern Med"},{"issue":"8","key":"1819_CR21","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens YA, Zhao N, Liu CC, Kanekiyo T, Yang AJ, Goate AM et al (2022) ApoE Cascade Hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110(8):1304\u20131317. https:\/\/doi.org\/10.1016\/j.neuron.2022.03.004","journal-title":"Neuron"},{"issue":"D1","key":"1819_CR22","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","volume":"47","author":"D Mendez","year":"2019","unstructured":"Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, F\u00e9lix E et al (2019) ChEMBL: towards direct deposition of bioassay data. Nucleic Acids Res 47(D1):D930-d940. https:\/\/doi.org\/10.1093\/nar\/gky1075","journal-title":"Nucleic Acids Res"},{"key":"1819_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030230","author":"A Mendsaikhan","year":"2019","unstructured":"Mendsaikhan A, Tooyama I, Walker DG (2019) Microglial progranulin: involvement in Alzheimer\u2019s disease and neurodegenerative diseases. Cells. https:\/\/doi.org\/10.3390\/cells8030230","journal-title":"Cells"},{"issue":"9","key":"1819_CR24","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1002\/alz.13062","volume":"19","author":"M Nassan","year":"2023","unstructured":"Nassan M, Daghlas I, Piras IS, Rogalski E, Reus LM, Pijnenburg Y et al (2023) Evaluating the association between genetically proxied ACE inhibition and dementias. Alzheimers Dement 19(9):3894\u20133901. https:\/\/doi.org\/10.1002\/alz.13062","journal-title":"Alzheimers Dement"},{"key":"1819_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.00185","volume":"12","author":"CR Noe","year":"2020","unstructured":"Noe CR, Noe-Letschnig M, Handschuh P, Noe CA, Lanzenberger R (2020) Dysfunction of the blood-brain barrier-a key step in neurodegeneration and dementia. Front Aging Neurosci 12:185. https:\/\/doi.org\/10.3389\/fnagi.2020.00185","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1819_CR26","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jalz.2017.05.006","volume":"14","author":"KL Rasmussen","year":"2018","unstructured":"Rasmussen KL, Tybj\u00e6rg-Hansen A, Nordestgaard BG, Frikke-Schmidt R (2018) Plasma apolipoprotein E levels and risk of dementia: A Mendelian randomization study of 106,562 individuals. Alzheimers Dement 14(1):71\u201380. https:\/\/doi.org\/10.1016\/j.jalz.2017.05.006","journal-title":"Alzheimers Dement"},{"issue":"1","key":"1819_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"AC Raulin","year":"2022","unstructured":"Raulin AC, Doss SV, Trottier ZA, Ikezu TC, Bu G, Liu CC (2022) ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol Neurodegener 17(1):72. https:\/\/doi.org\/10.1186\/s13024-022-00574-4","journal-title":"Mol Neurodegener"},{"issue":"8","key":"1819_CR28","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.tips.2021.11.015","volume":"43","author":"H Rhinn","year":"2022","unstructured":"Rhinn H, Tatton N, McCaughey S, Kurnellas M, Rosenthal A (2022) Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol Sci 43(8):641\u2013652. https:\/\/doi.org\/10.1016\/j.tips.2021.11.015","journal-title":"Trends Pharmacol Sci"},{"issue":"9347","key":"1819_CR29","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/s0140-6736(02)11667-9","volume":"360","author":"K Ritchie","year":"2002","unstructured":"Ritchie K, Lovestone S (2002) The dementias. Lancet 360(9347):1759\u20131766. https:\/\/doi.org\/10.1016\/s0140-6736(02)11667-9","journal-title":"Lancet"},{"issue":"4","key":"1819_CR30","doi-asserted-by":"publisher","first-page":"e70202","DOI":"10.1002\/dad2.70202","volume":"17","author":"AM Salih","year":"2025","unstructured":"Salih AM, Salatzki J, Wang Y, Akilu T, Maldonado C, Husain M et al (2025) Genetic associations of plasma proteomics with dementia subtypes and neuroimaging markers. Alzheimers Dement (Amst) 17(4):e70202. https:\/\/doi.org\/10.1002\/dad2.70202","journal-title":"Alzheimers Dement (Amst)"},{"issue":"10284","key":"1819_CR31","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/s0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE et al (2021) Alzheimer\u2019s disease. Lancet 397(10284):1577\u20131590. https:\/\/doi.org\/10.1016\/s0140-6736(20)32205-4","journal-title":"Lancet"},{"issue":"16","key":"1819_CR32","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA et al (2021) Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. JAMA 326(16):1614\u20131621. https:\/\/doi.org\/10.1001\/jama.2021.18236","journal-title":"JAMA"},{"issue":"7982","key":"1819_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu YH, Richardson TG et al (2023) Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622(7982):329\u2013338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6","journal-title":"Nature"},{"issue":"1","key":"1819_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40659-025-00598-2","volume":"58","author":"X Sun","year":"2025","unstructured":"Sun X, Hu X, Wei J, An H (2025) Uncovering leading compounds for alzheimer\u2019s disease treatment: mendelian randomization and virtual screening insights into plasma protein modulation. Biol Res 58(1):19. https:\/\/doi.org\/10.1186\/s40659-025-00598-2","journal-title":"Biol Res"},{"issue":"D1","key":"1819_CR35","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R et al (2023) The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51(D1):D638\u2013d646. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"1819_CR36","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1001\/jama.2009.812","volume":"301","author":"G Thanassoulis","year":"2009","unstructured":"Thanassoulis G, O\u2019Donnell CJ (2009) Mendelian randomization: nature\u2019s randomized trial in the post-genome era. JAMA 301(22):2386\u20132388. https:\/\/doi.org\/10.1001\/jama.2009.812","journal-title":"JAMA"},{"issue":"1","key":"1819_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05454-1","volume":"6","author":"A Tin","year":"2023","unstructured":"Tin A, Fohner AE, Yang Q, Brody JA, Davies G, Yao J et al (2023) Identification of circulating proteins associated with general cognitive function among middle-aged and older adults. Commun Biol 6(1):1117. https:\/\/doi.org\/10.1038\/s42003-023-05454-1","journal-title":"Commun Biol"},{"issue":"4","key":"1819_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.cell.2017.07.023","volume":"170","author":"TK Ulland","year":"2017","unstructured":"Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL et al (2017) TREM2 Maintains Microglial Metabolic Fitness in Alzheimer\u2019s Disease. Cell 170(4):649\u2013663e613. https:\/\/doi.org\/10.1016\/j.cell.2017.07.023","journal-title":"Cell"},{"issue":"5","key":"1819_CR39","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker KA, Chen J, Zhang J, Fornage M, Yang Y, Zhou L et al (2021) Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat Aging 1(5):473\u2013489. https:\/\/doi.org\/10.1038\/s43587-021-00064-0","journal-title":"Nat Aging"},{"issue":"1","key":"1819_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-023-00687-4","volume":"19","author":"L Wang","year":"2024","unstructured":"Wang L, Nyk\u00e4nen NP, Western D, Gorijala P, Timsina J, Li F et al (2024) Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer\u2019s disease. Mol Neurodegener 19(1):1. https:\/\/doi.org\/10.1186\/s13024-023-00687-4","journal-title":"Mol Neurodegener"},{"issue":"Web Server issu","key":"1819_CR41","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P et al (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38(Web Server issue):W214-220. https:\/\/doi.org\/10.1093\/nar\/gkq537","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"1819_CR42","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR et al (2018) DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res 46(D1):D1074\u2013d1082. https:\/\/doi.org\/10.1093\/nar\/gkx1037","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"1819_CR43","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1042\/bst20180211","volume":"47","author":"G Wu","year":"2019","unstructured":"Wu G, Quek AJ, Caradoc-Davies TT, Ekkel SM, Mazzitelli B, Whisstock JC et al (2019) Structural studies of plasmin inhibition. Biochem Soc Trans 47(2):541\u2013557. https:\/\/doi.org\/10.1042\/bst20180211","journal-title":"Biochem Soc Trans"},{"issue":"7","key":"1819_CR44","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.ajhg.2021.05.014","volume":"108","author":"H Xue","year":"2021","unstructured":"Xue H, Shen X, Pan W (2021) Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects. Am J Hum Genet 108(7):1251\u20131269. https:\/\/doi.org\/10.1016\/j.ajhg.2021.05.014","journal-title":"Am J Hum Genet"},{"issue":"1","key":"1819_CR45","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12974-020-01878-2","volume":"17","author":"J Yang","year":"2020","unstructured":"Yang J, Fu Z, Zhang X, Xiong M, Meng L, Zhang Z (2020) TREM2 ectodomain and its soluble form in Alzheimer\u2019s disease. J Neuroinflammation 17(1):204. https:\/\/doi.org\/10.1186\/s12974-020-01878-2","journal-title":"J Neuroinflammation"},{"issue":"12","key":"1819_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2024.100700","volume":"4","author":"M Yao","year":"2024","unstructured":"Yao M, Miller GW, Vardarajan BN, Baccarelli AA, Guo Z, Liu Z (2024) Deciphering proteins in Alzheimer\u2019s disease: a new Mendelian randomization method integrated with AlphaFold3 for 3D structure prediction. Cell Genom 4(12):100700. https:\/\/doi.org\/10.1016\/j.xgen.2024.100700","journal-title":"Cell Genom"},{"key":"1819_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178297","volume":"1007","author":"Y Yuan","year":"2025","unstructured":"Yuan Y, Wang S, Lian P, Yu Z, Gao X, Duan Y et al (2025) From plasma proteomics Mendelian randomization to neuropathological validation: the potential role of CTSH-GRN-TMEM106B and TREM2-IL-34 networks of microglia in Alzheimer\u2019s disease. Eur J Pharmacol 1007:178297. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178297","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1819_CR48","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12967-025-06317-5","volume":"23","author":"H Zhan","year":"2025","unstructured":"Zhan H, Cammann D, Cummings JL, Dong X, Chen J (2025) Biomarker identification for Alzheimer\u2019s disease through integration of comprehensive Mendelian randomization and proteomics data. J Transl Med 23(1):278. https:\/\/doi.org\/10.1186\/s12967-025-06317-5","journal-title":"J Transl Med"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01819-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01819-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:00:49Z","timestamp":1790236849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01819-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1819"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01819-2","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All summary-level GWAS datasets used in this study were obtained from publicly available databases or previously published studies, with detailed data sources listed in Table\u00a0\n                      \n                      and the corresponding cited publications. This study was based exclusively on publicly available, deidentified, summary-level genetic association data. Ethical approval and informed consent had been obtained in the original studies according to their respective protocols. No new human participants, animal experiments, biological samples, individual-level data, or identifiable personal information were involved; therefore, additional institutional ethical approval was not required. The study was conducted in accordance with the principles of the Declaration of Helsinki. All the authors have approved the final article for publication.","order":2,"name":"Ethics","label":"Informed Consent and Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"143"}}